Top

Published in:

01-01-2007 | Original Paper

Interactions of human tenascin-X domains with dermal extracellular matrix molecules

Authors: David Egging, Franka van den Berkmortel, Glen Taylor, Jim Bristow, Joost Schalkwijk

Published in: Archives of Dermatological Research | Issue 8/2007

Abstract

Tenascin-X (TNX) is a large 450 kDa extracellular matrix protein expressed in a variety of tissues including skin, joints and blood vessels. Deficiency of TNX causes a recessive form of Ehlers–Danlos syndrome characterized by joint hypermobility, skin fragility and hyperextensible skin. Skin of TNX deficient patients shows abnormal elastic fibers and reduced collagen deposition. The mechanism by which TNX deficiency leads to connective tissue alterations is unknown. Here we report that C-terminal domains of human TNX bind to major dermal fibrillar collagens and tropoelastin. We have mapped these interactions to the fibronectin type III repeat 29 (FNIII29) and the C-terminal fibrinogen domain (FbgX) of TNX. In addition we found that FNIII29 of TNX accelerates collagen fibrillogenesis in vitro. We hypothesize that TNX contributes to matrix stability and is possibly involved in collagen fibril formation.

Available only for authorised users

Bristow J, Tee MK, Gitelman SE, Mellon SH, Miller WL (1993) Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B. J Cell Biol 122:265–278PubMedCrossRef

Burch GH, Gong Y, Liu W, Dettman RW, Curry CJ, Smith L, Miller WL, Bristow J (1997) Tenascin-X deficiency is associated with Ehlers–Danlos syndrome (see comments). Nat Genet 17:104–108PubMedCrossRef

Egging DF, van Vlijmen I, Starcher B, Gijsen Y, Zweers MC, Blankevoort L, Bristow J, Schalkwijk J (2006) Dermal connective tissue development in mice: an essential role for tenascin-X. Cell Tissue Res 323:465–474PubMedCrossRef

Elefteriou F, Exposito J, Garrone R, Lethias C (2001) Binding of tenascin-X to decorin. FEBS Lett 495:44–47PubMedCrossRef

Elefteriou F, Exposito JY, Garrone R, Lethias C (1997) Characterization of the bovine tenascin-X. J Biol Chem 272:22866–22874PubMedCrossRef

Ikuta T, Sogawa N, Ariga H, Ikemura T, Matsumoto K (1998) Structural analysis of mouse tenascin-X: evolutionary aspects of reduplication of FNIII repeats in the tenascin gene family. Gene 217:1–13PubMedCrossRef

Jensen SA, Corbett AR, Knott V, Redfield C, Handford PA (2005) Ca2+ -dependent interface formation in fibrillin-1. J Biol Chem 280:14076–14084PubMedCrossRef

Kadler KE, Holmes DF, Trotter JA, Chapman JA (1996) Collagen fibril formation. Biochem J 316(Pt1):1–11PubMed

Kettle S, Yuan X, Grundy G, Knott V, Downing AK, Handford PA (1999) Defective calcium binding to fibrillin-1: consequence of an N2144S change for fibrillin-1 structure and function. J Mol Biol 285:1277–1287PubMedCrossRef

10.

Kozel BA, Wachi H, Davis EC, Mecham RP (2003) Domains in tropoelastin that mediate elastin deposition in vitro and in vivo. J Biol Chem 278:18491–18498PubMedCrossRef

11.

Lee SS, Knott V, Jovanovic J, Harlos K, Grimes JM, Choulier L, Mardon HJ, Stuart DI, Handford PA (2004) Structure of the integrin binding fragment from fibrillin-1 gives new insights into microfibril organization. Structure (Camb) 12:717–729CrossRef

12.

Lethias C, Descollonges Y, Boutillon MM, Garrone R (1996) Flexilin: a new extracellular matrix glycoprotein localized on collagen fibrils. Matrix Biol 15:11–19PubMedCrossRef

13.

Lethias C, Elefteriou F, Parsiegla G, Exposito JY, Garrone R (2001) Identification and characterization of a conformational heparin-binding site involving two fibronectin type iii modules of bovine tenascin-X. J Biol Chem 276:16432–16438PubMedCrossRef

14.

Lindor NM, Bristow J (2005) Tenascin-X deficiency in autosomal recessive Ehlers–Danlos syndrome. Am J Med Genet A 135(1):75–80PubMed

15.

Mao JR, Taylor G, Dean WB, Wagner DR, Afzal V, Lotz JC, Rubin EM, Bristow J (2002) Tenascin-X deficiency mimics Ehlers–Danlos syndrome in mice through alteration of collagen deposition. Nat Genet 30:421–425PubMedCrossRef

16.

Matsumoto K, Saga Y, Ikemura T, Sakakura T, Chiquet ER (1994) The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C. J Cell Biol 125:483–493PubMedCrossRef

17.

McGettrick AJ, Knott V, Willis A, Handford PA (2000) Molecular effects of calcium binding mutations in Marfan syndrome depend on domain context. Hum Mol Genet 9:1987–1994PubMedCrossRef

18.

Minamitani T, Ikuta T, Saito Y, Takebe G, Sato M, Sawa H, Nishimura T, Nakamura F, Takahashi K, Ariga H, Matsumoto K (2004) Modulation of collagen fibrillogenesis by tenascin-X and type VI collagen. Exp Cell Res 298:305–315PubMedCrossRef

19.

Morel Y, Bristow J, Gitelman SE, Miller WL (1989) Transcript encoded on the opposite strand of the human steroid 21-hydroxylase/complement component C4 gene locus. Proc Natl Acad Sci USA 86:6582–6586PubMedCrossRef

20.

Peeters ACTM, Kucharekova M, Timmermans J, van den Berkmortel FWPJ, Boers GH, Novakova IRO, Egging D, den Heijer M, Schalkwijk J (2004) A clinical and cardiovascular survey of Ehlers–Danlos syndrome patients with complete deficiency of tenascin-X. Neth J Med 62:23–25

21.

Reinhardt DP, Mechling DE, Boswell BA, Keene DR, Sakai LY, Bachinger HP (1997) Calcium determines the shape of fibrillin. J Biol Chem 272:7368–7373PubMedCrossRef

22.

Schalkwijk J, Zweers MC, Steijlen PM, Dean WB, Taylor G, Van Vlijmen IM, van Haren B, Miller WL, Bristow J (2001) A recessive form of the Ehlers–Danlos syndrome caused by tenascin-X deficiency. N Engl J Med 345:1167–1175PubMedCrossRef

23.

Tee MK, Thomson AA, Bristow J, Miller WL (1995) Sequences promoting the transcription of the human XA gene overlapping P450c21A correctly predict the presence of a novel, adrenal-specific, truncated form of tenascin-X. Genomics 28:171–178PubMedCrossRef

24.

Whiteman P, Downing AK, Handford PA (1998) NMR analysis of cbEGF domains gives new insights into the structural consequences of a P1148A substitution in fibrillin-1. Protein Eng 11:957–959PubMedCrossRef

25.

Whiteman P, Smallridge RS, Knott V, Cordle JJ, Downing AK, Handford PA (2001) A G1127S change in calcium-binding epidermal growth factor-like domain 13 of human fibrillin-1 causes short range conformational effects. J Biol Chem 276:17156–17162PubMedCrossRef

26.

Williams BR, Gelman RA, Poppke DC, Piez KA (1978) Collagen fibril formation. Optimal in vitro conditions and preliminary kinetic results. J Biol Chem 253:6578–6585PubMed

27.

Zweers MC, Bristow J, Steijlen PM, Dean WB, Hamel BC, Otero M, Kucharekova M, Boezeman JB, Schalkwijk J (2003) Haploinsufficiency of TNXB is associated with hypermobility type of Ehlers–Danlos syndrome. Am J Hum Genet 73:214–217PubMedCrossRef

28.

Zweers MC, Vlijmen-Willems IM, Van Kuppevelt TH, Mecham RP, Steijlen PM, Bristow J, Schalkwijk J (2004) Deficiency of tenascin-X causes abnormalities in dermal elastic fiber morphology. J Invest Dermatol 122:885–891PubMedCrossRef

Title: Interactions of human tenascin-X domains with dermal extracellular matrix molecules
Authors: David Egging
Franka van den Berkmortel
Glen Taylor
Jim Bristow
Joost Schalkwijk
Publication date: 01-01-2007
Publisher: Springer-Verlag
Published in: Archives of Dermatological Research / Issue 8/2007
Print ISSN: 0340-3696
Electronic ISSN: 1432-069X
DOI: https://doi.org/10.1007/s00403-006-0706-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Interactions of human tenascin-X domains with dermal extracellular matrix molecules

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2007

In vivo levels of IL-4, IL-10, TGF-β1 and IFN-γ mRNA of the peripheral blood mononuclear cells in patients with alopecia areata in comparison to those in patients with atopic dermatitis

Immunohistochemical study on topoisomerase IIα, Ki-67 and cytokeratin-19 in oral lichen planus lesions

Blood urokinase plasminogen activator system in chronic urticaria

Variations of the melanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanoma

N-Linked neutral oligosaccharides in the stratum corneum of normal and ichthyotic skin

Modelling the human epidermis in vitro: tools for basic and applied research